Categories: AIAll postsAnalysts

Is Celestica still a buy?

The stock has been on fire since September, but Stifel analyst Ruben Roy thinks there is still money to be made on Celestica (Celestica Stock Quote, Chart, News, Analysts, Financials NYSE:CLS).

The analyst says CLS may be partly driven by AI hype at the moment, but argues that something more long-term is afoot.

“While we have seen multiple re-rating as CLS has been identified as a beneficiary of AI infrastructure spend, we believe that we remain in the early stages of a long-tailed investment cycle,” he wrote. “Recent new HPS customer program wins would indicate that CLS continues to execute against this longer-term opportunity. We also expect gradual stabilization and improvement in the company’s Advanced Technology Solutions (ATS) segment as we progress through 2025.”

As reported by The Globe and Mail, Roy February 4th maintained his “Buy” rating and price target of (US) $140.00 on Celestica.

“We believe Celestica will continue to benefit from multiple expansion as the company continues to execute on adding specialized capabilities to serve the emerging needs of a broad and diverse customer base.” Roy added. “Believe that a focused and long, multi-year effort through investments in engineering capabilities, strategic manufacturing footprint and process innovation, Celestica has emerged as a key partner to leading U.S. hyperscaler customers. We expect Celestica to benefit, longer-term, from a market leadership position as AI infrastructure investments continue over the next several year.”

Tagged with: cls
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Should you sell your Tilray stock?

Haywood Securities analyst Neal Gilmer says Tilray Brands’ (Tilray Brands Stock Quote, Chart, News, Analysts, Financials TSX:TLRY) fiscal Q1 results… [Read More]

2 days ago

KITS Eyecare is the right stock for price-sensitive times, analyst says

Haywood Securities analyst Gianluca Tucci says KITS Eyecare’s (KITS Eyecare Stock Quote, Chart, News, Analysts, Financials TSX:KITS) Q3 pre-release confirmed… [Read More]

2 days ago

This analyst just cut his price target on Telus

Desjardins Securities analyst Jerome Dubreuil lowered his target on Telus (Telus Stock Quote, Chart, News, Analysts, Financials TSX:T) to $13.00… [Read More]

4 days ago

This analyst just cut his price target on BCE

National Bank Financial analyst Adam Shine says BCE’s (BCE Stock Quote, Chart, News, Analysts, Financials TSX:BCE) near-term setup depends on… [Read More]

5 days ago

Is it time to sell your Wildbrain stock?

RBC Dominion Securities analyst Drew McReynolds says WildBrain (WildBrain Stock Quote, Chart, News, Analysts, Financials TSX:WILD) now has a clearer… [Read More]

5 days ago

Wellstar Technologies wins $10.00 target at RBC

RBC Dominion Securities analyst Paul Treiber says Wellstar Technologies (Wellstar Technologies Stock Quote, Chart, News, Analysts, Financials TSXV:WSTR) is positioned… [Read More]

6 days ago